Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration - PubMed (original) (raw)
Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration
C L Halbert et al. J Virol. 1997 Aug.
Abstract
The ability of recombinant adeno-associated virus (AAV) vectors to integrate into the host genome and to transduce nondividing cells makes them attractive as vehicles for gene delivery. In this study, we assessed the ability of several AAV vectors to transduce airway cells in rabbits by measuring marker gene expression. AAV vectors that transferred either a beta-galactosidase (beta-gal) or a human placental alkaline phosphatase (AP) gene were delivered to one lobe of the rabbit lung by use of a balloon catheter placed under fluoroscopic guidance. We observed vector-encoded beta-gal or AP staining almost exclusively in the epithelial and smooth muscle cells in the bronchus at the region of balloon placement. The overall efficiency of transduction in the balloon-treated bronchial epithelium was low but reached 20% in some areas. The majority of the staining was in ciliated cells but was also observed in basal cells and airway smooth muscle cells. We observed an 80-fold decrease in marker-positive epithelial cells during the 60-day period after vector infusion, whereas the number of marker-positive smooth muscle cells stayed constant. Although treatment with the topoisomerase inhibitor etoposide dramatically enhanced AAV transduction in primary airway epithelial cells in culture, treatment of rabbits did not improve transduction rates in the airway. Vector readministration failed to produce additional transduction events, which correlated with the appearance of neutralizing antibodies. These results indicate that both readministration and immune modulation will be required in the use of AAV vectors for gene therapy to the airway epithelium.
Similar articles
- Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure.
Halbert CL, Standaert TA, Wilson CB, Miller AD. Halbert CL, et al. J Virol. 1998 Dec;72(12):9795-805. doi: 10.1128/JVI.72.12.9795-9805.1998. J Virol. 1998. PMID: 9811715 Free PMC article. - Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes.
Halbert CL, Rutledge EA, Allen JM, Russell DW, Miller AD. Halbert CL, et al. J Virol. 2000 Feb;74(3):1524-32. doi: 10.1128/jvi.74.3.1524-1532.2000. J Virol. 2000. PMID: 10627564 Free PMC article. - Repeated delivery of adeno-associated virus vectors to the rabbit airway.
Beck SE, Jones LA, Chesnut K, Walsh SM, Reynolds TC, Carter BJ, Askin FB, Flotte TR, Guggino WB. Beck SE, et al. J Virol. 1999 Nov;73(11):9446-55. doi: 10.1128/JVI.73.11.9446-9455.1999. J Virol. 1999. PMID: 10516053 Free PMC article. - Adeno-associated virus as a gene therapy vector: strategies to neutralize the neutralizing antibodies.
Lotfinia M, Abdollahpour-Alitappeh M, Hatami B, Zali MR, Karimipoor M. Lotfinia M, et al. Clin Exp Med. 2019 Aug;19(3):289-298. doi: 10.1007/s10238-019-00557-8. Epub 2019 May 3. Clin Exp Med. 2019. PMID: 31054018 Review. - Immune responses to adeno-associated virus vectors.
Zaiss AK, Muruve DA. Zaiss AK, et al. Curr Gene Ther. 2005 Jun;5(3):323-31. doi: 10.2174/1566523054065039. Curr Gene Ther. 2005. PMID: 15975009 Review.
Cited by
- The Expression and Function of the Small Nonstructural Proteins of Adeno-Associated Viruses (AAVs).
Kuz CA, McFarlin S, Qiu J. Kuz CA, et al. Viruses. 2024 Jul 29;16(8):1215. doi: 10.3390/v16081215. Viruses. 2024. PMID: 39205189 Free PMC article. Review. - Bilateral gene therapy in children with autosomal recessive deafness 9: single-arm trial results.
Wang H, Chen Y, Lv J, Cheng X, Cao Q, Wang D, Zhang L, Zhu B, Shen M, Xu C, Xun M, Wang Z, Tang H, Hu S, Cui C, Jiang L, Yin Y, Guo L, Zhou Y, Han L, Gao Z, Zhang J, Yu S, Gao K, Wang J, Chen B, Wang W, Chen ZY, Li H, Shu Y. Wang H, et al. Nat Med. 2024 Jul;30(7):1898-1904. doi: 10.1038/s41591-024-03023-5. Epub 2024 Jun 5. Nat Med. 2024. PMID: 38839897 Free PMC article. Clinical Trial. - Molecular Mechanisms in Pathophysiology of Mucopolysaccharidosis and Prospects for Innovative Therapy.
Ago Y, Rintz E, Musini KS, Ma Z, Tomatsu S. Ago Y, et al. Int J Mol Sci. 2024 Jan 17;25(2):1113. doi: 10.3390/ijms25021113. Int J Mol Sci. 2024. PMID: 38256186 Free PMC article. Review. - Cryo-electron Microscopy of Adeno-associated Virus.
Stagg SM, Yoshioka C, Davulcu O, Chapman MS. Stagg SM, et al. Chem Rev. 2022 Sep 14;122(17):14018-14054. doi: 10.1021/acs.chemrev.1c00936. Epub 2022 May 16. Chem Rev. 2022. PMID: 35575684 Free PMC article. Review. - Host Immune Responses after Suprachoroidal Delivery of AAV8 in Nonhuman Primate Eyes.
Chung SH, Mollhoff IN, Mishra A, Sin TN, Ngo T, Ciulla T, Sieving P, Thomasy SM, Yiu G. Chung SH, et al. Hum Gene Ther. 2021 Jul;32(13-14):682-693. doi: 10.1089/hum.2020.281. Epub 2021 Apr 8. Hum Gene Ther. 2021. PMID: 33446041 Free PMC article.
References
- Nature. 1994 Oct 27;371(6500):802-6 - PubMed
- Mol Cell Biol. 1990 Aug;10(8):4239-42 - PubMed
- Nat Genet. 1994 Oct;8(2):148-54 - PubMed
- J Virol. 1995 Mar;69(3):1473-9 - PubMed
- Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5719-23 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical